ArticleAlzheimer's & dementia (New York, N. Y.)

Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years.

Marwan Sabbagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.